ArticleFrontiers in medicine2021

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis.

Ji-Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.